This is a dumb conversation because the landscape of the discussion is one where the costs increase exponentially as the disability being serviced becomes more rare, and there isn't an objectively correct answer.
Maybe, but going by that 5% of the population have severe food allergies and only ~1% use wheelchairs, so if we accept wheelchair ramps etc. as being a worthwhile investment (which I do) then proper labeling and disclosure of allergens seems reasonable as well?
Maybe, but going by that 5% of the population have severe food allergies and only ~1% use wheelchairs, so if we accept wheelchair ramps etc. as being a worthwhile investment (which I do) then proper labeling and disclosure of allergens seems reasonable as well?